BAYER CHEMICALS TO TAKE A SPIN Split-off of chemicals will shift firm�s focus to life sciences

BIOTECH SCORES BIG THIRD-QUARTER GAINS Substantial revenue and earnings growth continued unabated for yet another quarter

DRUG EARNINGS RALLY IN THE THIRD QUARTER Major pharmaceutical firms see improvement in sales and earnings as the year progresses

It Lives for 29 Years? A lawsuit filed April 11 in the U.S. District Court in Los Angeles has grabbed

Big pharma plays hard ball with little biotech If you play with the big boys you might get hurt…

USDA Sued Over Drug-Growing Crops A coalition of environmental groups and consumer advocates sued the U.S. Agriculture Department in federal

Staffing needs seen in biotech industry A top Labor Department official said yesterday that community colleges nationwide could boost their

Getting Investors’ Pulses Beating Again Any biotech slowdown will be temporary, says VC Nick Galakatos, who believes 2004’s ‘promising products’

Getting Investors’ Pulses Beating Again Any biotech slowdown will be temporary, says VC Nick Galakatos, who believes 2004’s ‘promising products’

Financial Snapshot For October 2003 Stocks On New Plateau